Robert Orlowski, Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day: Study of conditioning, cell dose, schedule and AL amyloidosis ASCT outcome finds full-dose MEL, no rest day and infused CD34 ≥4.5×106/kg -> superior OS; higher TRM if poor PS, hi NT-proBNP, albumin <2.5, lower CD34, no rest.”
Authors: Eli Muchtar, Vaishali Sanchorawala, Hamza Hassan, Ute Hegenbart, Stefan Schönland, Hila Magen, Eden Shkury, Caitlin Sarubbi, Heather Landau, Morie Gertz et al.
More posts featuring Robert Orlowski.
